ICTC 2024 Co-Chairs
Mohamad Mohty
France
Bio
Mohamad Mohty
Professor Mohty obtained his medical degree from the University of Montpellier, France, and his PhD from the University of Marseille, France. He also undertook post-doctoral work at the Hematology Department, Imperial College, Hammersmith Hospital, London, UK.
Professor Mohty is also head of a translational research team (INSERM team N°7) at the Saint-Antoine Research centre in Paris and his research is focused on the pathophysiology and immunobiology of normal and pathological antigen-presenting cells, especially the impact of novel immunomodulatory agents such as proteasome inhibitors, IMiDs and hypomethylating agents.
He has a special clinical focus on the development of reduced-toxicity conditioning regimens, immunotherapy and different aspects of therapy of acute leukemia and multiple myeloma.
Professor Mohty serves on the board of the European Society for Blood and Marrow Transplantation (EBMT), and the “Intergroupe Francophone du Myelome” (IFM). He is a member of the American Society of Hematology, American Society for Clinical Oncology, American Society for Blood and Marrow Transplantation, European Hematology Association, International Society for Experimental Hematology, and EBMT.
Professor Mohty has published more than 430 peer-reviewed articles in the field of stem cell transplantation, leukemia and myeloma, in different hematology and immunology journals.
He also serves as Editor-in-Chief of the journal Bone Marrow Transplantation, as Associate Editor for Leukemia, European Journal of Haematology and Blood Cancer Journal, as member of the editorial board of Haematologica, and as a regular reviewer in different immunology, hematology, and cancer journals such as Blood, The Lancet, and Nature Reviews.
He Huang
China
Bio
He Huang
Didier Blaise
France
Bio
Didier Blaise
Prof Didier Blaise, MD: Aix Marseille Univ (AMU), Management Sport Cancer Lab (MSC EA4670) Institut Paoli Calmettes (IPC) Marseille, France.
Didier Blaise, MD is professor of hematology at Aix Marseille University. He is director of the transplant and cellular immunotherapy program at Institut Paoli Calmettes, Marseille. He has contributed to more than 600 peer reviewed publications. His major focuses are optimization, social and economic evaluation of innovation in allogeneic transplantation.
Arnon Nagler
Israel
Bio
Arnon Nagler
Chaim Sheba Medical Center, Israel
- Director of the Division of Hematology, Chaim Sheba Medical Center, Israel
- Director of Bone Marrow transplantation and Cord Blood Bank, Chaim Sheba Medical Center, Israel
- Professor of Medicine at the Tel Aviv University, Tel Aviv, Israel
- One of the pioneers of the non-myeloablative and reduced intensity/toxicity allogeneic transplantations for both malignant and non-malignant disorders (Blood 1998)
- Established the first public cord blood bank and performed the first cord blood transplanataion in Israel
- Leader of the Alternative donor subcommittee of the ALWP of the EBMT from 2008-2010
- Leader of the RIC subcommittee of the ALWP of the EBMT – since 2010
- Serves on the Editorial Board of several BMT and Hematology Journals and is a Section Editor for Leukemia
- Chair of the Acute Leukemia Working Party (ALWP) of the EBMT
Dr Nagler received his medical training at the Hebrew University-Hadassah Medical School, Jerusalem, Israel; he then carried out a Postdoctoral research fellowship in hematology and bone marrow transplantation at “Stanford University Hospital” Palo Alto, CA, in the USA, from 1986 to 1990.
Dr Nagler serves on the Board of Directors of Netcord organization of cord blood banks and was the Netcord Threasurer from 2010-2013.
Dr Nagler has received several awards including the best scientific abstract award of the ASBMT/CIBMR Tandem meeting (2004) and the best clinical abstract award of the NMDP Council Meeting (2004). In addition, Dr Nagler is a popular speaker and has made numerous, invited, international presentations and many Oral presentations on almost annual basis in all international transplantation and hematology meetings – ASH,ASBMT/CIBMTR, EBMT, EHA, Exp Hematology (including a presentation at the presidential symposium) and invited presentation at the Gordon conference (Boston USA).